ESSA Gross Profit vs Other Operating Expenses Analysis

EPIX Stock

USD 1.73 0.01 0.57%

ESSA Pharma financial indicator trend analysis is much more than just examining ESSA Pharma latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ESSA Pharma is a good investment. Please check the relationship between ESSA Pharma Gross Profit and its Other Operating Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.

Gross Profit vs Other Operating Expenses

Gross Profit vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ESSA Pharma Gross Profit account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.

The correlation between ESSA Pharma's Gross Profit and Other Operating Expenses is -0.83. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of ESSA Pharma, assuming nothing else is changed. The correlation between historical values of ESSA Pharma's Gross Profit and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of ESSA Pharma are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Gross Profit i.e., ESSA Pharma's Gross Profit and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.83

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Gross Profit

Gross profit is a required income statement account that reflects total revenue of ESSA Pharma minus its cost of goods sold. It is profit before ESSA Pharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ESSA Pharma. It is also known as ESSA Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from ESSA Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ESSA Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.Selling General Administrative is likely to drop to about 8.2 M in 2025. Tax Provision is expected to grow at the current pace this year

ESSA Pharma fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Liab	Net Tangible Assets	Other Assets	Long Term Debt	Net Receivables	Inventory	Property Plant Equipment	Property Plant And Equipment Net	Common Stock Shares Outstanding
Total Assets		0.59	0.38	1.0	-0.89	-0.91	0.32	0.88	0.41	0.51	0.93	0.44	0.7	-0.04	1.0	-0.01	0.97	-0.3	0.98	0.66	0.59	-0.15	0.93	0.66	0.75	0.95
Other Current Liab	0.59		0.01	0.59	-0.53	-0.28	-0.12	0.43	0.11	0.35	0.37	0.62	0.0	-0.17	0.6	-0.06	0.41	-0.16	0.46	0.48	0.26	-0.04	0.35	0.54	0.27	0.39
Total Current Liabilities	0.38	0.01		0.35	-0.42	-0.41	0.7	0.43	0.57	0.19	0.44	0.56	0.26	0.72	0.38	0.26	0.38	0.15	0.35	0.3	0.58	0.15	0.32	0.59	0.45	0.31
Total Stockholder Equity	1.0	0.59	0.35		-0.89	-0.91	0.3	0.88	0.39	0.49	0.93	0.41	0.71	-0.09	1.0	-0.02	0.97	-0.32	0.99	0.65	0.58	-0.15	0.94	0.64	0.75	0.96
Net Debt	-0.89	-0.53	-0.42	-0.89		0.8	-0.34	-0.98	-0.42	-0.42	-0.91	-0.44	-0.71	0.01	-0.89	0.0	-0.86	0.26	-0.89	-0.62	-0.55	0.13	-0.8	-0.7	-0.82	-0.84
Retained Earnings	-0.91	-0.28	-0.41	-0.91	0.8		-0.47	-0.82	-0.46	-0.57	-0.87	-0.26	-0.86	-0.05	-0.9	-0.03	-0.97	0.27	-0.95	-0.44	-0.65	0.19	-0.93	-0.54	-0.76	-0.97
Accounts Payable	0.32	-0.12	0.7	0.3	-0.34	-0.47		0.36	0.56	0.52	0.4	0.43	0.42	0.66	0.32	0.24	0.4	0.54	0.35	0.19	0.27	0.18	0.38	0.48	0.57	0.36
Cash	0.88	0.43	0.43	0.88	-0.98	-0.82	0.36		0.44	0.41	0.91	0.4	0.8	0.03	0.88	0.03	0.89	-0.27	0.9	0.56	0.58	-0.14	0.83	0.64	0.87	0.86
Non Current Assets Total	0.41	0.11	0.57	0.39	-0.42	-0.46	0.56	0.44		0.44	0.42	0.33	0.46	0.46	0.41	0.59	0.45	0.05	0.42	0.31	0.42	0.13	0.51	0.19	0.66	0.41
Non Currrent Assets Other	0.51	0.35	0.19	0.49	-0.42	-0.57	0.52	0.41	0.44		0.46	0.35	0.46	0.41	0.51	0.06	0.55	0.31	0.5	0.32	0.43	-0.24	0.51	0.26	0.51	0.54
Cash And Short Term Investments	0.93	0.37	0.44	0.93	-0.91	-0.87	0.4	0.91	0.42	0.46		0.32	0.75	0.02	0.93	0.01	0.92	-0.28	0.94	0.77	0.57	-0.14	0.9	0.62	0.77	0.9
Other Current Assets	0.44	0.62	0.56	0.41	-0.44	-0.26	0.43	0.4	0.33	0.35	0.32		0.08	0.46	0.44	0.12	0.33	0.13	0.33	0.31	0.49	0.32	0.22	0.76	0.44	0.28
Other Stockholder Equity	0.7	0.0	0.26	0.71	-0.71	-0.86	0.42	0.8	0.46	0.46	0.75	0.08		0.03	0.7	0.07	0.84	-0.25	0.81	0.21	0.55	-0.19	0.83	0.31	0.83	0.86
Total Liab	-0.04	-0.17	0.72	-0.09	0.01	-0.05	0.66	0.03	0.46	0.41	0.02	0.46	0.03		-0.04	0.22	-0.01	0.55	-0.07	0.01	0.41	-0.05	-0.04	0.16	0.21	-0.07
Total Current Assets	1.0	0.6	0.38	1.0	-0.89	-0.9	0.32	0.88	0.41	0.51	0.93	0.44	0.7	-0.04		-0.01	0.97	-0.3	0.98	0.66	0.6	-0.16	0.93	0.66	0.75	0.95
Intangible Assets	-0.01	-0.06	0.26	-0.02	0.0	-0.03	0.24	0.03	0.59	0.06	0.01	0.12	0.07	0.22	-0.01		0.02	0.2	0.0	-0.04	0.02	0.17	0.02	0.02	0.12	0.01
Common Stock	0.97	0.41	0.38	0.97	-0.86	-0.97	0.4	0.89	0.45	0.55	0.92	0.33	0.84	-0.01	0.97	0.02		-0.29	0.99	0.55	0.62	-0.17	0.97	0.57	0.81	1.0
Other Liab	-0.3	-0.16	0.15	-0.32	0.26	0.27	0.54	-0.27	0.05	0.31	-0.28	0.13	-0.25	0.55	-0.3	0.2	-0.29		-0.32	-0.17	-0.4	0.01	-0.27	-0.08	-0.07	-0.31
Net Tangible Assets	0.98	0.46	0.35	0.99	-0.89	-0.95	0.35	0.9	0.42	0.5	0.94	0.33	0.81	-0.07	0.98	0.0	0.99	-0.32		0.6	0.59	-0.16	0.97	0.6	0.8	0.99
Other Assets	0.66	0.48	0.3	0.65	-0.62	-0.44	0.19	0.56	0.31	0.32	0.77	0.31	0.21	0.01	0.66	-0.04	0.55	-0.17	0.6		0.28	-0.03	0.57	0.45	0.42	0.5
Long Term Debt	0.59	0.26	0.58	0.58	-0.55	-0.65	0.27	0.58	0.42	0.43	0.57	0.49	0.55	0.41	0.6	0.02	0.62	-0.4	0.59	0.28		-0.25	0.52	0.52	0.48	0.6
Net Receivables	-0.15	-0.04	0.15	-0.15	0.13	0.19	0.18	-0.14	0.13	-0.24	-0.14	0.32	-0.19	-0.05	-0.16	0.17	-0.17	0.01	-0.16	-0.03	-0.25		-0.17	0.17	0.11	-0.19
Inventory	0.93	0.35	0.32	0.94	-0.8	-0.93	0.38	0.83	0.51	0.51	0.9	0.22	0.83	-0.04	0.93	0.02	0.97	-0.27	0.97	0.57	0.52	-0.17		0.41	0.82	0.97
Property Plant Equipment	0.66	0.54	0.59	0.64	-0.7	-0.54	0.48	0.64	0.19	0.26	0.62	0.76	0.31	0.16	0.66	0.02	0.57	-0.08	0.6	0.45	0.52	0.17	0.41		0.47	0.54
Property Plant And Equipment Net	0.75	0.27	0.45	0.75	-0.82	-0.76	0.57	0.87	0.66	0.51	0.77	0.44	0.83	0.21	0.75	0.12	0.81	-0.07	0.8	0.42	0.48	0.11	0.82	0.47		0.79
Common Stock Shares Outstanding	0.95	0.39	0.31	0.96	-0.84	-0.97	0.36	0.86	0.41	0.54	0.9	0.28	0.86	-0.07	0.95	0.01	1.0	-0.31	0.99	0.5	0.6	-0.19	0.97	0.54	0.79

Click cells to compare fundamentals

ESSA Pharma Account Relationship Matchups

ESSA Pharma fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	198.2M	169.5M	149.1M	128.1M	147.3M	154.7M
Other Current Liab	39.2M	36.4M	1.4M	773.5K	889.5K	845.0K
Total Current Liabilities	3.9M	2.3M	3.5M	3.3M	3.8M	3.0M
Total Stockholder Equity	194.0M	167.1M	145.6M	128.1M	147.3M	154.7M
Net Debt	(137.5M)	(56.9M)	(33.6M)	(103.4M)	(93.0M)	(88.4M)
Retained Earnings	(117.8M)	(152.9M)	(179.5M)	(208.0M)	(187.2M)	(177.8M)
Accounts Payable	1.4M	954.6K	2.0M	2.4M	2.8M	1.5M
Cash	137.8M	57.1M	33.7M	103.7M	119.3M	125.2M
Non Current Assets Total	567.7K	446.0K	325.3K	552.4K	635.3K	401.0K
Cash And Short Term Investments	194.9M	57.1M	148.1M	126.8M	145.8M	153.1M
Other Current Assets	2.2M	1.8M	585.4K	636.5K	731.9K	1.2M
Other Stockholder Equity	36.4M	44.0M	49.0M	130.2M	149.7M	157.2M
Total Liab	4.2M	2.4M	3.5M	3.5M	4.0M	4.5M
Total Current Assets	197.6M	169.5M	148.8M	127.6M	146.7M	154.0M
Common Stock	131.1M	277.4M	278.1M	278.2M	319.9M	335.9M
Net Tangible Assets	49.0M	79.2M	194.0M	167.1M	192.2M	201.8M
Other Assets	198.2M	(446.0K)	115.4M	24.1M	27.7M	30.8M
Net Receivables	489.0K	6.2K	135.1K	163.0K	146.7K	139.3K
Short Term Investments	57.1M	110.2M	114.4M	23.1M	26.5M	32.7M
Liabilities And Stockholders Equity	198.2M	169.5M	149.1M	128.1M	147.3M	75.6M
Short Term Debt	120.7K	133.8K	80.3K	124.1K	111.6K	106.1K
Property Plant And Equipment Net	308.3K	186.5K	68.0K	295.5K	339.8K	356.8K
Common Stock Shares Outstanding	38.5M	44.0M	44.1M	44.3M	50.9M	53.5M
Non Current Liabilities Total	230.6K	77K	(71.0)	205.2K	184.7K	175.5K
Property Plant And Equipment Gross	308.3K	186.5K	68.0K	295.5K	339.8K	356.8K
Capital Lease Obligations	331.0K	210.3K	80.3K	329.3K	378.6K	397.6K
Short Long Term Debt Total	331.0K	209.8K	80.3K	329.3K	296.3K	281.5K
Net Invested Capital	194.0M	167.1M	145.6M	124.6M	143.3M	107.6M
Net Working Capital	193.7M	166.7M	145.3M	124.3M	142.9M	106.0M
Capital Stock	277.4M	278.1M	278.2M	279.9M	321.8M	213.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ESSA Gross Profit vs Other Operating Expenses Analysis

Gross Profit vs Other Operating Expenses

Gross Profit vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Gross Profit

Other Operating Expenses

ESSA Pharma fundamental ratios Correlations

ESSA Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ESSA Pharma fundamental ratios Accounts

Also Currently Popular

Additional Tools for ESSA Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Common Stock Shares Outstanding	+ 1.0	Common Stock
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Net Tangible Assets	+ 0.99	Common Stock

Cash	- 0.98	Net Debt
Common Stock Shares Outstanding	- 0.97	Retained Earnings
Common Stock	- 0.97	Retained Earnings
Net Tangible Assets	- 0.95	Retained Earnings
Inventory	- 0.93	Retained Earnings
Cash And Short Term Investments	- 0.91	Net Debt